CDCA 250 mg tablets (Chenodal; lot #004949) were kindly supplied by Travere Therapeutics (San Diego, CA). Pravastatin 80 mg tablets were obtained from Accord Healthcare (Durham, NC). Metformin 500 mg tablets were obtained from Granules Pharmaceuticals (Chantilly, VA). Placebo tablets were manufactured at the University of Maryland Good Manufacturing Practice facility using
PROSOLV EASYtab SP (JRS PHARMA, Weissenborn, Germany). The FGF19 human enzyme‐linked immunosorbent assay (ELISA) kit was obtained from Invitrogen (Waltham, MA). Liquid‐chromatography tandem mass spectrometry (
LC–MS/MS) grade solvents were purchased from Fisher Scientific (Pittsburgh, PA). Pravastatin was obtained from United States Pharmacopeia (Rockville, MD). Pravastatin‐d
3 was obtained from Toronto Research Chemicals (North York, ON, Canada).
Bile acid standards and stable isotope labeled
Bile acid standards were purchased from Sigma Aldrich (St. Louis, MO), Toronto Research Chemicals (North York, ON, Canada), Steraloids (Newport, RI), Cambridge Isotope Laboratories (Tewksbury, MA), or CDN Isotopes (Pointe‐Claire, QC, Canada). ISOLUTE PLD+ phospholipid depletion columns were purchased from Biotage (Uppsala, Sweden).
Metry M., Krug S.A., Karra V.K., Kane M.A., Fink J.C., Shu Y., Wang H, & Polli J.E. (2022). Differential effects of metformin‐mediated BSEP repression on pravastatin and bile acid pharmacokinetics in humans: A randomized controlled trial. Clinical and Translational Science, 15(10), 2468-2478.